FEATURES
Why life sciences must build Recall Ready systems now
From paracetamol contamination to failing defibrillators, recent recall events show how fragile response mechanisms remain. Pete Gillett, founder of Marketpoint Recall, explores why life sciences firms must modernise recall operations before regulatory, financial and reputational costs spiral further.
In mid‑2025,...
Serious disease research takes big step forward in UK
Insmed recently opened a new R&D facility in Cambridge focused on synthetic rescue for serious diseases. Dr Tom Heightman, SVP of Research at the global biopharmaceutical, explains why the company is focused on UK expansion.
Insmed specialises in striving to...
Global warming ‘accelerates antibiotic resistance in soils’
An international study involving researchers from Durham University reveals that climate change is accelerating the rate of development and global abundances of antibiotic resistance bacteria in soils.
The findings, published in the journal Nature Ecology & Evolution, highlight a new...
AI: reimagining AI healthcare
The UK can overcome challenges and harness AI to address the immense pressures on the NHS, says Pratik Maroo, Senior Vice President and Head – Healthcare and Life Sciences, Zensar.
The UK Prime Minister’s Plan for Change focuses on how...
How AI is driving repurposing of drugs for rare diseases
Dr Anton Yuryev, consulting director, Bioinformatics and Data Science, Elsevier, explores two case studies where researchers have used AI to find drugs that can be repurposed for rare conditions.
There are more than 300 million people worldwide living with a...
Rules of protein stability are a billion years old
The rules required to make proteins stable are much simpler than previously thought, according to new research.
Published in the journal Science, the study has taken an important step towards learning the rules of protein stability, which may help protein...
Spinal cord injuries healed with bioelectricity
A groundbreaking bioelectric implant has restored movement in rats after spinal cord injuries.
The breakthrough offers new hope for an effective treatment for humans suffering from loss of sensation and function due to spinal cord injury.
The implant is developed by...
Stroke AI software hailed as ‘revolutionary’
An AI software platform has tripled the number of stroke patients achieving functional independence, from 16% to 48%, according to a study by the Royal Berkshire Hospital.
Additional data from the largest real-world evaluation of stroke AI imaging showed that...
Scotland’s total body PET scanner
UK’s world-class imaging platform extends to Scotland.
Scotland’s first total-body scanner is in situ at the Royal Infirmary of Edinburgh, meaning the National PET (Positron Emission Tomography) Imaging Platform network is now operational across the whole UK.
It’s part of a...
Parkinson’s: How the affected side shapes disease course
A team from UNIGE and HUG has shown that the side on which the first symptoms of the disease appear – left or right – influences patients’ cognitive and emotional symptoms.
Parkinson’s disease often begins asymmetrically, affecting either the right...
Research integrity under stress
Dekel Faruhi, VP of Product Adoption at Proofig AI, examines the pressures that U.S. institutions face in 2025, and how research integrity is essential to academia’s very survival.
American academia is facing an incredible amount of political and financial pressure.
Following...
Robotics ‘transforming’ cell therapy
A breakthrough partnership could make personalised, life-saving cancer treatments affordable and widely available.
A new robotic biomanufacturing cluster achieves a 74% cost reduction for life-saving cell therapies, according to developer Multiply Labs.
The breakthrough, published in peer-reviewed studies with UCSF, leverages...
‘Good vibrations’ improve lab-grown tissues
McGill researchers develop safe, scalable vibration technique to improve lab-grown tissues.
Researchers in McGill’s Department of Mechanical Engineering have discovered a safe and low-cost method of engineering living materials such as tissues, organs and blood clots.
By simply vibrating these materials...
The UK’s AI Healthcare Revolution
The Plan for Change focuses on how technology will be used to improve public services. For healthcare, in particular, the government is committed to bringing analogue NHS into the digital age. Pratik Maroo, Senior Vice President and Head –...
Why new drugs are effective for Alzheimer’s
Amyloid beta is one of the toxic proteins which builds up in clumps or ‘aggregates’ in the brains of people affected by Alzheimer’s.
Several drugs targeting the protein have been tested in trials over recent years. These drugs are antibodies...
Green footprint of digital vs. traditional clinical trials compared
The new initiative will collect pharma and CRO data to refine industry carbon measurement of technologies like remote monitoring and eConsent, informing more sustainable trial design.
The Pistoia Alliance, a global, not-for-profit alliance for collaboration in life sciences R&D, is launching the...
The rapid rise of decentralised science
Blockchain and open-access technology are transforming scientific publishing, says Philipp Koellinger, CEO and co-founder of open science firm, DeSci Labs.
For centuries, the way we publish and evaluate scientific research has remained largely unchanged. Researchers submit their work to journals,...
AI’s impact on healthcare reliant on building trust
AI could revolutionise healthcare, but not without experts addressing privacy & security concerns as well as existing concerns over industry medical knowledge and practices.
The use of artificial intelligence (AI) in healthcare is growing rapidly. But while it is already...
Can bioprinting cut infection rates?
3D bioprinting technology offers a promising solution to healthcare infection challenges, says Vidmantas Šakalys, CEO of Vital3D Technologies.
Healthcare-associated infections (HAIs) remain a significant concern in modern medicine, with approximately one in 31 hospital patients in the US experiencing at least...
‘Greedy’ genes linked to Labradors and people
Multiple genes associated with obesity have been found in Labrador dogs … and humans!
The dog gene found to be most strongly associated with obesity in Labradors is called DENND1B, which humans also carry.
DENND1B was found to directly affect a...
Biotech trends for 2026: The Digital and AI Revolution
The speed of change in biotech is breathtaking, and looking ahead to 2026, several key trends will shape its future, driven by the integration of digital technologies and advanced analytics, says Kevin Cramer, CEO, Sapio Sciences.
The biotechnology industry is...
AI robotic labs will ‘accelerate’ new treatments for deadly infections
Liverpool is the base for new AI-powered, robotic labs to accelerate development of treatments for deadly diseases, supported by £10m of Innovation Zone funding.
The High Containment Level 3 labs, located at the Liverpool School of Tropical Medicine (LSTM) and...
Aston University installs £1.5m mass spectrometer to study biological membranes
The £1.5m mass spectrometer will enable the study of proteins, lipids and metabolites in cell membranes in exceptional detail.
Aston Institute for Membrane Excellence (AIME) and Aston University College of Health and Life Sciences received a grant of £1.5m from...
Medical device design enters fourth dimension
A new project aims to revolution medical device engineering by incorporating a fourth dimension – time.
The 4D Health Tech initiative addresses a critical gap in medical device design: neglect of time-dependent changes in the human body.
Traditional medical devices fail...
Bacon in Space? Lab-grown fat cells a ’game-changer’ for cultivated meat
Pig fat cell production could transform lab-grown meat development, with rare combination of reliable and stable cell growth.
A source of fat cells from pigs has been developed in the lab, offering scientists and food manufacturers a promising tool for...
World’s first leather made from T-Rex DNA
A unique partnership says it is pioneering a cruelty-free and eco-friendly alternative to luxury leather… using prehistoric DNA.
The collaboration combines genomic engineering, advanced tissue engineering and creativity to produce a sustainable high-quality material engineered from synthesised T-Rex DNA.
The venture...
The crabs that glow to hide in coral
Tiny crabs have evolved to use fluorescence as camouflage in coral reefs.
During a night dive in the Red Sea, Ph.D student Susanne Bähr noticed the strange phenomenon, saying: “I had been working with these crabs for some time, so...
Worm slime could revolutionise bioplastics
McGill researchers want to harness a natural process that enables slime’s transformation from liquid to fibre and back again.
A new discovery about the slime ejected by velvet worms could revolutionise sustainable material design, according to a study by McGill...
‘Organ-on-a-chip’ alternative to animal testing
Bioengineers at Queen Mary University of London have taken a significant step forward in the development of laboratory-based models of human tissues which may be used as alternatives to animal testing.
The group develops organ-on-a-chip technology in which human cells...
Could cell death discovery hold the key to slower ageing on Earth and beyond?
Experts are exploring the emerging role of necrosis in ageing— and its potential to reshape how we treat age-linked conditions.
Necrosis is a form of cell death historically viewed as an unregulated and terminal event.
But now a top team of...
